ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場2019-2023

◆英語タイトル:Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019-2023
◆商品コード:IRTNTR31494
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月17日
◆ページ数:130
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、ヨーロッパ、北米、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Technavio社の本調査レポートでは、ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場について調べ、ヒト免疫不全ウイルス(HIV)迅速検査キットの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、ヒト免疫不全ウイルス(HIV)迅速検査キットの市場規模をセグメンテーション別(エンドユーザー別(診断センター、病院・診療所)、種類別(HIV迅速イムノアッセイテスト、HIV迅速分子診断テスト)、)と地域別(アジア、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社はヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場規模が2019-2023期間中に年平均7%成長すると予測しています。
・サマリー
・レポートの範囲
・ヒト免疫不全ウイルス(HIV)迅速検査キットの市場状況
・ヒト免疫不全ウイルス(HIV)迅速検査キットの市場規模
・ヒト免疫不全ウイルス(HIV)迅速検査キットの市場予測
・ヒト免疫不全ウイルス(HIV)迅速検査キットの世界環境:ファイブフォース分析
・市場セグメンテーション:エンドユーザー別(診断センター、病院・診療所)
・市場セグメンテーション:種類別(HIV迅速イムノアッセイテスト、HIV迅速分子診断テスト)
・ヒト免疫不全ウイルス(HIV)迅速検査キットの顧客状況
・主要地域別市場規模:アジア、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market: About this market :Human immunodeficiency virus rapid test kits are used for the detection of HIV antibodies present in the body. The HIV rapid tests provide results in few minutes, thereby eliminating the need for longer waiting period. Technavio’s human immunodeficiency virus rapid test kits market analysis considers the revenue generation based on end-users that includes diagnostic centers, and hospitals and clinics. Our analysis also considers the sales of human immunodeficiency virus rapid test kits in North America, Europe, Asia, and ROW. In 2018, the diagnostic centers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing awareness about the benefits of early detection play a significant role in the diagnostic centers segment to maintain their market position. Also, our global human immunodeficiency virus rapid test kits market report looks at factors such as the rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and the high prevalence of HIV. However, the non-availability of rapid HIV products in limited resource settings, limited healthcare services in developing regions, and lack of trained professionals may hamper the growth of the human immunodeficiency virus rapid test kits industry over the forecast period.
Global human immunodeficiency virus rapid test kits market: Overview
Growing demand for point-of-care testing for HIV
The demand for point-of-care testing for HIV is increasing at a significant rate as POC testing technologies are affordable and easily accessible. Point-of-care testing can also detect HIV at an early stage, which is essential to start primary treatment and prevent the onset of AIDS. Thus, the growing demand for point-of-care testing for HIV will fuel the growth of the HIV test kits market at a CAGR of more than 7% during the forecast period.
Availability of a broad range of HIV rapid test kits by vendors
Vendors in the market are increasingly focusing on manufacturing innovative test kits to cater to the growing demand for HIV testing. The demand is increasing mainly driven by a paradigm shift from treatment to the preventive healthcare system. Thus, the availability of a broad range of HIV rapid test kits by vendors is identified as a key HIV test kits market trends that will fuel the growth of the market during the forecast period.
For the detailed list of factors that will drive the global human immunodeficiency virus rapid test kits market during the forecast period 2019-2023, click here.
Competitive Landscape
With the presence of few major players, the global human immunodeficiency virus rapid test kits market is moderately concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV test kits manufacturers, that include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., and QIAGEN Group.

Also, the human immunodeficiency virus rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY END-USER
Market segmentation by end-user
Comparison by end-user
Diagnostic centers – Market size and forecast 2018-2023
Hospitals and clinics – Market size and forecast 2018-2023
Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY TYPE
HIV rapid immunoassay test
HIV rapid molecular diagnostic test
PART 09: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America – Market size and forecast 2018-2023
Europe – Market size and forecast 2018-2023
Asia – Market size and forecast 2018-2023
ROW – Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
Efforts to increase pre-marital screenings for HIV
Increasing clinical studies by researchers and promotional
activities by manufacturers
Availability of a broad range of HIV rapid test kits by vendors
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Abbott Laboratories
Bio-Rad Laboratories Inc.
Danaher Corp.
F. Hoffmann-La Roche Ltd.
QIAGEN Group
PART 15: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
LOE
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Diagnostic centers – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Diagnostic centers – Year-over-year growth 2019-2023 (%)
Exhibit 21: Hospitals and clinics – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Hospitals and clinics – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by end-user
Exhibit 24: Customer landscape
Exhibit 25: Market share of global human immunodeficiency virus (HIV) rapid test kits market by test type 2018
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America – Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott Laboratories – Vendor overview
Exhibit 45: Abbott Laboratories – Business segments
Exhibit 46: Abbott Laboratories – Organizational developments
Exhibit 47: Abbott Laboratories – Geographic focus
Exhibit 48: Abbott Laboratories – Segment focus
Exhibit 49: Abbott Laboratories – Key offerings
Exhibit 50: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 51: Bio-Rad Laboratories Inc. – Business segments
Exhibit 52: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 53: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 54: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 55: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 56: Danaher Corp. – Vendor overview
Exhibit 57: Danaher Corp. – Business segments
Exhibit 58: Danaher Corp. – Organizational developments
Exhibit 59: Danaher Corp. – Geographic focus
Exhibit 60: Danaher Corp. – Segment focus
Exhibit 61: Danaher Corp. – Key offerings
Exhibit 62: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 63: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 64: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 66: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 68: QIAGEN Group – Vendor overview
Exhibit 69: QIAGEN Group – Product segments
Exhibit 70: QIAGEN Group – Organizational developments
Exhibit 71: QIAGEN Group – Geographic focus
Exhibit 72: QIAGEN Group – Segment focus
Exhibit 73: QIAGEN Group – Key offerings
Exhibit 74: Validation techniques employed for market sizing
Exhibit 75: Definition of market positioning of vendors




【掲載企業】

Abbott Laboratories
Bio-Rad Laboratories Inc.
Danaher Corp.
F. Hoffmann-La Roche Ltd.
QIAGEN Group

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヒト免疫不全ウイルス(HIV)迅速検査キットの世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆